Works matching IS 09024441 AND DT 2023 AND VI 111 AND IP 4
Results: 22
Response to "Efficacy of COVID‐19 vaccination in adult patients with sickle cell disease: Comment".
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Effects of anti‐Xa activity monitoring on the outcome of high‐risk pregnancies treated with a prophylactic dose of low‐molecular‐weight heparin.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 4, p. 655, doi. 10.1111/ejh.14060
- By:
- Publication type:
- Article
Despite warnings, co‐medication with proton pump inhibitors and dasatinib is common in chronic myeloid leukemia, but XS004, a novel oral dasatinib formulation, provides reduced pH‐dependence, minimizing undesirable drug–drug interactions
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 4, p. 644, doi. 10.1111/ejh.14059
- By:
- Publication type:
- Article
Long‐term clinical outcomes and healthcare utilization of sickle cell disease patients with COVID‐19: A 2.5‐year follow‐up study.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 4, p. 636, doi. 10.1111/ejh.14058
- By:
- Publication type:
- Article
Efficacy of isatuximab in combination with steroids for the treatment of relapsed/refractory multiple myeloma patients exhibiting only biochemical progression—A single center retrospective study.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 4, p. 628, doi. 10.1111/ejh.14057
- By:
- Publication type:
- Article
How can artificial intelligence help rehabilitation programs for people with hemophilia in the coming decades?
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 4, p. 671, doi. 10.1111/ejh.14056
- By:
- Publication type:
- Article
Clinical implications of NUP98::NSD1 fusion at diagnosis in adult FLT3‐ITD positive AML.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 4, p. 620, doi. 10.1111/ejh.14055
- By:
- Publication type:
- Article
Demographics and outcomes of hemoglobin genotype in hospitalized patients with COVID‐19 and sickle cell disease in the United States.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 4, p. 611, doi. 10.1111/ejh.14054
- By:
- Publication type:
- Article
Appropriateness of inpatient intravenous iron therapy in a Swiss tertiary care hospital.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 4, p. 601, doi. 10.1111/ejh.14053
- By:
- Publication type:
- Article
Platelet transfusions and predictors of bleeding in patients with myelodysplastic syndromes.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 4, p. 592, doi. 10.1111/ejh.14049
- By:
- Publication type:
- Article
Next generation sequencing in routine diagnostics of mature non‐Hodgkin's B‐cell lymphomas.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 4, p. 583, doi. 10.1111/ejh.14048
- By:
- Publication type:
- Article
Venetoclax‐based therapy for relapsed or refractory acute myeloid leukaemia following intensive induction chemotherapy.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 4, p. 573, doi. 10.1111/ejh.14046
- By:
- Publication type:
- Article
Reduced prophylactic effect of tixagevimab–cilgavimab in patients with hematological malignancies and without antibody response after SARS‐COV‐2 vaccination.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 4, p. 668, doi. 10.1111/ejh.14045
- By:
- Publication type:
- Article
Differences in patient‐reported outcomes (PROs) by disease severity in light chain (AL) amyloidosis.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 4, p. 536, doi. 10.1111/ejh.14036
- By:
- Publication type:
- Article
Prognostic value of the mutation types and dynamics of FLT3‐ITD in acute myeloid leukemia.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 4, p. 562, doi. 10.1111/ejh.14044
- By:
- Publication type:
- Article
Influence of conditioning regimen intensity on outcomes post‐allogeneic hematopoietic cell transplantation for acute myeloid leukemia in complete morphological remission.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 4, p. 553, doi. 10.1111/ejh.14041
- By:
- Publication type:
- Article
Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A—Final efficacy and safety results from the NuProtect study.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 4, p. 544, doi. 10.1111/ejh.14040
- By:
- Publication type:
- Article
Psychological toxicity in classical hematology.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 4, p. 516, doi. 10.1111/ejh.14038
- By:
- Publication type:
- Article
Rare presence of Charcot–Leyden crystals in acute myeloid leukemia.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 4, p. 662, doi. 10.1111/ejh.14037
- By:
- Publication type:
- Article
Efficacy of COVID‐19 vaccination in adult patients with sickle cell disease: Comment.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 4, p. 666, doi. 10.1111/ejh.14042
- By:
- Publication type:
- Article
Comparing end‐of‐life care of hematologic malignancy versus solid tumor patients in a tertiary care center.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 4, p. 528, doi. 10.1111/ejh.14035
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 4, p. 513, doi. 10.1111/ejh.13800
- Publication type:
- Article